To investigate the impact of performing short bouts of seated upper body activity on postprandial blood glucose and insulin levels during prolonged sitting.
| INTRODUCTION
Greater time spent sedentary (defined as sitting or reclining with low energy expenditure [EE]), 1 is increasingly being recognized as an independent risk factor for morbidity (especially type 2 diabetes) 2-5 and mortality, 2, [4] [5] [6] associations that persist after controlling for moderate-tovigorous physical activity (MVPA) levels. [2] [3] [4] [5] Associations between sedentary behaviour and health may be attenuated, however, when engaging in very high levels of physical activity (typically in the region of ≥60 min/d). 6 Epidemiological findings have been strengthened by recent experimental evidence showing beneficial effects of interrupting prolonged sitting on markers of metabolic health, particularly postprandial glycaemia. For example, interrupting sitting time with regular bouts of light-intensity [7] [8] [9] [10] and moderate-intensity 8, 11, 12 walking have been shown to be effective at reducing postprandial blood glucose levels in overweight and obese adults, 8 those with dysglycaemia, 7, 12 those with diagnosed type 2 diabetes, 10 and healthy, normal-weight populations. 9, 11 Breaking up prolonged sitting time with standing 7, 13, 14 or light resistance activities 10 (while in a standing posture) have also proven to be effective.
Interrupting sitting time with upright (non-seated) activities therefore appears to be a viable way of attenuating postprandial glucose.
Whether these improvements can be replicated by introducing upper body muscle activity while maintaining a seated posture is currently unknown. Addressing this question will help clarify whether it is the posture of sitting that is driving the association with poor health or whether it is the resulting generalized muscular inactivity. Importantly, investigating non-weight-bearing strategies for reducing sedentary behaviour will also have important clinical implications for individuals who have restricted mobility or find standing difficult. In addition, strategies for breaking sedentary behaviour that have been investigated to date not only overlook those with weight-bearing difficulty, but have also been criticized for being disruptive and non-conducive to the working day. 15 Given that seated strategies would not require vacating the desk area, this could present a more appealing option for sedentary workers.
The aim of the present study was to investigate whether performing short, frequent bouts of seated upper body activity (using similar
EEs to light-intensity walking) can attenuate postprandial glycaemia.
| MATERIALS AND METHODS

| Trial design
Each participant attended the research centre on three separate occasions between May and August 2016. The first visit involved consent, familiarization and EE measurement. This was followed by two experimental condition visits that were at least 7 days apart. A randomized crossover design was used, whereby each participant took part in 2 experimental treatment conditions in a random order, thereby acting as their own controls. Order randomization was conducted by a statistician using an online tool. Because of the nature of the trial, participants were not blinded to their randomized order, but all outcomes, including blood assays, were analysed blinded to the experimental condition from which they derived. Before commencing the present study, we received ethical approval from the National Health Service (NHS) East Midlands -Leicester South Research Ethics Committee. This trial was registered with ClinicalTrials.gov (NCT02909894). This left a total of 13 participants who went on to complete the trial.
| Participants
This process is shown in Figure 1 .
| Consent, familiarization and EE assessment visit
On arrival, a researcher described in detail all study procedures and written informed consent was obtained.
As a part of the screening process, a venous blood sample was taken to assess HbA1c levels, and confirm absence of type 2 diabetes (HbA1c <6.5% [<47.5 mmol/mol]). 19 Body weight (Tanita TBE 611:
Tanita, West Drayton, UK), waist circumference (midpoint between lower costal margin and iliac crest) and height were measured to the nearest 0.1 kg, 0.5 and 0.5 cm, respectively.
During this first visit, we also undertook arm ergometry EE testing.
Specifically, we sought to identify the power output (watts) necessary to elicit the desired EE during the main experimental condition. To allow comparison of metabolic responses to arm ergometry with previous findings that have examined the impact of light walking (3 km/h), [7] [8] [9] [10] we aimed to match participants' arm ergometry EE to their 3 km/h walking EE. To achieve this, EE was captured: (a) while at rest; (b) while walking at 3 km/h and (c) while performing arm ergometry at various power outputs. In order for EE to be derived throughout each of these three domains, participants wore a face mask that was directly attached to a breath-by-breath gas-analysis system (Metalyser 3B; Cortex Biophysik, Leipzig, Germany). Oxygen uptake and carbon dioxide production were used to calculate EE via indirect calorimetry. 20 Before undertaking each testing occasion (detailed below), the gas analyser was calibrated according to the manufacturer's recommendations.
To assess EE while at rest (phase a), each participant sat quietly (refraining from movement) for 30 minutes. Expired gas data were collected over the final 15 minutes of this 30-minute period, once values had stabilized.
To assess EE while walking at 3 km/h (phase b), participants wore the face mask while walking on a motor driven treadmill (Technogym Excite 700) for 10 minutes. Expired gas data were collected in the lat- 
| Experimental procedure
Participants were asked to avoid alcohol and caffeine for 48 hours preceding experimental conditions and to replicate their diet in the 24 hours before main trials. Given that the influence of an acute bout of physical activity on insulin sensitivity can persist for 48 hours, 21 avoidance of MVPA for this timeframe was also instructed. GENEActiv accelerometers were worn in the 2 days leading up to each experimental condition to confirm compliance with the exercise restriction.
Participants fasted from 10.00 PM on the evening before main trials, with only water permitted to drink. On arrival at the research centre, participants had a cannula fitted into an accessible vein from which 10-mL samples were 1 screen failure -Diagnosed with type 2 diabetes 13 were order-randomized to the 2 repeated-measure experimental conditions All 13 individuals completed both experimental conditions, providing a 'complete case' analysis. Figure 2 ) and sampling continued in the same fashion at 30, 60, 120 and 180 minutes afterward. Participants were supervised by study staff to ensure compliance with the protocol and were asked to wear an activPAL monitor to objectively confirm sitting time during both experimental conditions. Ad libitum water consumption was made consistent between conditions.
| Measuring mood during experimental conditions
The Feeling Scale 22 was used to quantify mood/effect prior to each blood sample (10 times in total) for both experimental conditions.
Participants were asked to estimate their current mood state on an 11-point scale (+5 = very good; 0 = neutral; −5 = very bad) throughout the day.
| Safety
Incidences of hypoglycaemia (defined as glucose levels <4 mmol/L) during the final measurement period before lunch (3 hours after breakfast) and in the final measurement period of the day (3 hours after lunch) were also investigated during each experimental condition.
| Free-living activity monitor processing
ActivPAL proprietary software (activPAL Professional V5.9.1.1) was used to create processed csv event files in order to quantify postural data collected during the 7.5-hour experimental conditions. GENEActiv .bin files were analysed using R package GGIR version 1.2-11
(http://cran.r-project.org). 23, 24 Habitual data were included if participants had >16 hours of wear-time recorded during the 24-hour day of interest, and if they had >3 valid days of data collected. MVPA was calculated using an acceleration threshold of 100 mg. 25 MVPA bouts were identified as ≥10 minutes of consecutive 5-second epochs, where 80% of epochs were equal to, or higher than, the 100-mg threshold. Time spent in the ranges 0 to 50 mg and 50 to 100 mg was used to establish sedentary (minus sleep time) and light activity, respectively.
A summary of all GENEActiv data collected at each phase of the study is detailed in Table S1 . ActivPAL data collected during experimental conditions is detailed in Table S2 .
| Biochemical analysis
Glucose (primary outcome measure) was analysed on the day of collection by the University Hospitals of Leicester pathology department using standard quality controlled enzymatic assays with commercially available kits (Beckman, High Wycombe, UK).
Centrifugated plasma samples (spun at 3000 g for 10 minutes
immediately after extraction) were stored in −80 C freezers. Insulin (secondary outcome measure) was analysed from these collectively at the end of the trial using an electrochemiluminescence assay (Meso Scale Discovery). Each sample was run in duplicate to ensure reliability of readings. Duplicate sample values with ≥20% variability were reanalysed. Ambient conditions of the laboratory were kept consistent.
| Sample size
The primary aim of the present study was to assess the difference in postprandial glucose levels between the two experimental treatment conditions. Assuming a population standard deviation (s.d.) of 2.5 mmol/L/h in glucose incremental area under the curve (iAUC) and a within-person correlation of 0.5, 13 participants were required to complete the study in order to detect a difference of 1.8 mmol/L/h in blood glucose iAUC between the experimental conditions with 90% power (α = 0.05).
| Statistical analysis
Missing glucose and insulin data during the experimental conditions (highlighted in Table S3 ) resulted from an inability to draw enough FIGURE 2 Analyte AUC data between experimental conditions blood from the cannula at given time points and accounted for~3.7% of required samples (19 out of 520). These 19 missing data points were imputed via a regression model used previously. 7 The iAUCs of glucose and insulin were calculated for each experimental condition. Total area under the curve (AUC) was calculated by applying the trapezium rule.
Subtraction of the fasting area from this total then gave a single value representing iAUC for each participant. Using iAUC as opposed to total AUC is common practice in acute interventions where fasting levels should be unaffected by the intervention. 26 Each outcome (glucose and insulin iAUC) was compared between treatments using a paired samples t-test. Data from the Feeling Scale were averaged across each condition and analysed using a paired t-test. All statistical analyses were performed using IBM SPSS Statistics (Version 22.0) and statistical significance was set to P < .05 throughout. unless specified otherwise. For the experimental data, the unstandardized residuals were checked for normality.
| RESULTS
The descriptive characteristics of those who completed the present study are summarized in Table 1 (n = 13). The study characteristics
show that the EE of arm ergometry breaks conducted in the experimental condition was similar to that achieved through a light-intensity walk at 3 km/h (4.5 vs 4.6 kcal/min, respectively); however, the average respiratory exchange ratio (RER) was higher during arm ergometry compared with light-intensity walking (1.00 vs 0.84; P < 0.001).
| Experimental data
Biochemical results collected during each experimental condition are shown in Figure 2 . 
| Physical activity and sedentary time data
Physical activity and sedentary behaviour data are shown in Table S1 . 
| Mood, tolerance and safety
Mean AE s.d. self-reported feeling scores throughout the day were 3.1 AE 1.1 and 2.7 AE 1.2 for the prolonged sitting-only and arm ergometry breaks conditions, respectively (P = .101 for difference), demonstrating positive mood states during both conditions. All participants completed the required number of arm ergometry bouts, and none reported musculoskeletal pain or discomfort.
Two participants did have asymptomatic hypoglycaemia during the final measurement of the day during the arm ergometry breaks condition, with no incidences reported during the prolonged sitting condition.
| DISCUSSION
The present study is the first to investigate the metabolic impact of Given that arm ergometry breaks were implemented while main- The present study suggests an alternative strategy to help regulate postprandial glycaemia while sitting, in a population at high risk of type 2 diabetes. Not only are arm ergometry breaks an alternative strategy, but they may even act as a sole strategy for individuals with weight-bearing difficulty such as wheelchair users and those with severe peripheral neuropathy, which is thought to affect up to half of all people diagnosed with type 2 diabetes. 32 Given the disruptive nature of alternative strategies, such as frequent walking breaks, seated activity may also appeal to office workers who find it difficult to leave their desk or office space at regular intervals throughout the day. Portable lightweight desktop arm ergometers may also be of use in a hospital environment to improve postprandial glycaemia in patients who are bed-bound yet able to sit upright.
The main strength of the present study lies in the exploration of a novel strategy to alleviate the deleterious impacts of prolonged sitting bouts on postprandial glycaemia in a population at high risk of developing type 2 diabetes recruited through a primary care setting; however, it is important to acknowledge some limitations.
Although comparing our findings to those observed when introducing 3 km/h walking breaks, 7-10 we did not include a third experimental walking condition which may have strengthened our
conclusions. In addition, this study was not designed to elucidate the potential mechanisms underpinning the acute reductions in postprandial glucose and insulin concentrations observed when employing seated activity breaks; however, the study was specifically designed to establish proof-of-concept for the efficacy of employing seated arm ergometry breaks as a method of acutely reducing postprandial glucose concentrations during prolonged sedentary behaviour. This is clinically important given that exaggerated postprandial glucose oscillations are associated with the development of type 2 diabetes, 33 cardiovascular disease [33] [34] [35] and obesity. 33 Even small elevations in postprandial glycaemia are thought to contribute to the development of atherosclerosis and subsequent coronary heart disease events. 36 Although a sample size of 13 provided adequate power for comparison between experimental conditions, the small sample makes it harder to generalize findings beyond the specific population recruited to this study. Given that efforts to manipulate blood glucose control are thought to be more pronounced in those with worse glycaemia, 37 the potential of such interventions in a population diagnosed with type 2 diabetes would also be intriguing and warrants further investigation. Future intervention studies observing the impacts of seated activity breaks using more ecologically valid regimes in settings outside of the laboratory (such as the home, or in a hospital environment) would also be of interest. The ability to emulate reductions in postprandial glycaemia through regular bouts of electro-stimulated muscular contractions would also be an interesting focal point for future research given recent links to improved insulin sensitivity 38 and its potential application to non-weight-bearing populations. Likewise, given that arm ergometers are not easily accessible to all, engaging in seated upper body resistance band exercises could also pose as an intriguing alternative for future research. Future research exploring the minimum time, frequency and intensity that should be used when implementing activity breaks to bring about clinically significant improvements in postprandial glycaemia is warranted to promote more attractive, feasible and sustainable strategies. In addition,
given that 2 participants were found to be over the threshold for asymptomatic hypoglycaemia at the end of the arm ergometer condition, the safety of the current regime needs further investigation in those at high risk or with diagnosed type 2 diabetes, particularly in the 24 hours after the intervention. Further research applying hyperinsulinaemic-euglycaemic clamp techniques could also be used to give more detailed insight into the dynamics of glucose metabolism when employing seated upper body breaks during prolonged sedentary behaviour.
In conclusion, the present study shows that seated arm ergometry breaks are a viable way to attenuate postprandial glycaemia. This suggests that breaking up the posture of sitting may not be necessary to elicit glycaemic benefit and that interventions to reduce sedentary behaviour should not focus solely on postural change.
